| Kim Knowles, PHD | |
|
15 Pleasant Hill Rd Ste 204, Scarborough, ME 04074-9688 | |
| (207) 799-6166 | |
| (207) 885-1062 |
| Full Name | Kim Knowles |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 32 Years |
| Location | 15 Pleasant Hill Rd Ste 204, Scarborough, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083677975 | NPI | - | NPPES |
| MM793002 | Other | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PS977 (Maine) | Primary |
| Entity Name | Kim B Knowles Phd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780939769 PECOS PAC ID: 0143476515 Enrollment ID: O20120820000201 |
News Archive
Even though much of the population in developing countries is involved in agriculture, food security is virtually out of reach. Often the only resort is to purchase a cow, buffalo, or sheep, to provide a steady supply of fresh milk, a nutritious staple of a daily diet. But how to preserve it safely? Refrigeration and boiling are costly - and often impossible due to sporadic electricity.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
A new way to deliver therapeutic proteins inside the body uses an acoustically sensitive carrier to encapsulate the proteins and ultrasound to image and guide the package to the exact location required, according to Penn State researchers. Ultrasound then breaks the capsule, allowing the protein to enter the cell.
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kim Knowles, PHD Po Box 2121, South Portland, ME 04116-2121 Ph: (207) 767-1260 | Kim Knowles, PHD 15 Pleasant Hill Rd Ste 204, Scarborough, ME 04074-9688 Ph: (207) 799-6166 |
News Archive
Even though much of the population in developing countries is involved in agriculture, food security is virtually out of reach. Often the only resort is to purchase a cow, buffalo, or sheep, to provide a steady supply of fresh milk, a nutritious staple of a daily diet. But how to preserve it safely? Refrigeration and boiling are costly - and often impossible due to sporadic electricity.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
A new way to deliver therapeutic proteins inside the body uses an acoustically sensitive carrier to encapsulate the proteins and ultrasound to image and guide the package to the exact location required, according to Penn State researchers. Ultrasound then breaks the capsule, allowing the protein to enter the cell.
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
› Verified 5 days ago
Dr. Martin Robert Finkelstein, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 20 Dylan Dr, Scarborough, ME 04074 Phone: 207-219-8975 | |
Dr. Audrey Donna Stempel, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 636 Us Route 1, Suite B, Scarborough, ME 04074 Phone: 207-205-0289 Fax: 207-883-3144 | |
John A, Millhouse, EDD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 Professional Drive, Scarborough, ME 04074 Phone: 207-883-0711 Fax: 207-883-2204 | |
Dr. Wendy N. Kjeldgaard, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 Us Route 1 Ste R2, Scarborough, ME 04074 Phone: 207-939-5446 | |
Dr. Jean Fahey, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 27 Gorham Rd, Suite 13, Scarborough, ME 04074 Phone: 781-862-3219 | |
Catherine Spedden, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 Professional Drive, Scarborough, ME 04074 Phone: 207-883-0711 Fax: 207-883-2204 |